YOLFTbeta
Jeonjinbio Co. Ltd

Jeonjinbio Co. Ltd

110020 · KQ · Basic Materials / Specialty Chemicals

2,035.00KRW+20.00 (+0.99%)

Price History

Full chart

Market Stats

Previous Close2,015.00
Open2,015.00
Day Range1,998.00 – 2,075.00
52-Week Range1,482.00 – 3,485.00
Volume17.33K
Market Cap18.62B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.48
50-Day Avg1,989.54
200-Day Avg2,134.44

About

Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products. Jeonjin Bio Co., Ltd. was founded in 2004 and is headquartered in Daegu, South Korea.

Company Details

  • SectorBasic Materials
  • IndustrySpecialty Chemicals
  • CEOMr. Taehun Lee
  • Employees0
  • Headquarters295, Seongseo gongdan buk-Ro,, Daegu, South Korea, Korea
  • Websitehttps://www.jjbio.co.kr

Leadership

  • Mr. Taehun LeeChief Executive Officer · b. 1973

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.02B4.81B3.14B1.38B3.95B3.87B3.21B7.79B15.68B19.27B13.69B
Growth (%)-+138.31%-34.79%-55.85%+185.24%-2.09%-16.87%+142.48%+101.18%+22.91%-28.94%
Cost of Revenue1.33B2.40B1.88B1.25B1.86B1.65B1.85B5.79B10.81B13.22B9.91B
Gross Profit685.87M2.41B1.26B133.07M2.09B2.22B1.36B2.01B4.87B6.05B3.78B
Gross Margin33.99%50.18%40.12%9.61%52.84%57.32%42.42%25.74%31.06%31.40%27.60%
Operating Expense3.14B5.31B4.14B3.25B4.04B4.38B4.39B5.06B6.68B5.13B4.12B
Operating Income-2.45B-2.90B-2.88B-3.12B-1.96B-2.17B-3.03B-3.05B-1.81B923.67M-342.85M
Operating Margin-121.38%-60.31%-91.75%-225.32%-49.58%-56.01%-94.26%-39.17%-11.53%4.79%-2.50%
EBITDA-------313.80M-3.41B6.12B340.06M
EBITDA Margin-------4.03%-21.74%31.76%2.48%
Net Income-2.93B-3.07B-3.04B-3.40B-1.46B-3.42B-2.11B-3.11B-6.44B4.35B-195.81M
Net Income Margin-145.25%-63.92%-96.97%-245.50%-37.03%-88.40%-65.59%-39.94%-41.07%22.55%-1.43%
R&D36.76M195.76M191.83M361.39M464.74M344.95M363.84M421.95M447.75M361.75M438.06M
R&D as % of Total Revenue1.82%4.07%6.12%26.10%11.77%8.92%11.32%5.41%2.86%1.88%3.20%
Interest Expense0000356.69M515.62M865.67M2.03B1.20B432.26M326.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%9.03%13.34%26.93%26.11%7.62%2.24%0.00%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.21B5.83B4.06B7.12B6.41B18.69B24.82B17.87B17.70B18.85B18.51B
Total Liabilities7.95B3.55B3.83B3.21B3.51B7.41B14.02B8.36B11.48B1.19B1.10B
Total Equity1.27B2.28B229.96M3.91B2.90B11.28B10.80B9.51B6.22B17.66B17.41B
Cash1.15B506.52M1.05B5.33B4.16B8.92B317.00K18.21M1.69B92.00K6.41B
Total Debt--1.98B-2.54B7.04M-----
Net Debt-------3.25B3.62B--

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.95B-181.90M-413.19M-2.16B-1.30B-2.31B-2.38B-3.71B-300.60M3.01B483.19M
Investing Cash Flow447.02M-122.05M-209.99M223.56M-800.10M-5.84B-1.86B-4.31B-33.52M755.05M-
Financing Cash Flow1.35B-342.20M1.17B6.22B923.51M12.91B10.63B-5.93B693.66M811.00M-
Capital Expenditure117.47M148.79M2.42M26.95M700.73M5.80B1.93B2.13B671.64M394.36M790.76M
Free Cash Flow-----3.84B-8.15B-4.32B-5.84B-972.25M2.61B-307.57M
FCF to OCF----295.26%352.69%181.06%157.38%323.43%86.88%-63.65%

Earnings

Report DateDec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Jan 31, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------
EPS Actual-318.94-116.76-110.92-120.7963.68-89.88-170.44-110.66-245.32-154.40-46.58-143.753.00-202.83-7.78-174.87-92.29-167.95-270.78-81.74-367.09-35.72405.1662.8573.46-42.3211.5937.66-28.54-18.87-24.14
Surprise-------------------------------
Timing--------------------Pre-market----------

Key Statistics & Ratios

Market Cap18.62B
Enterprise Value12.14B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.36
Price / Book1.10
Revenue (TTM)13.71B
Gross Profit (TTM)3.53B
EBITDA140.45M
Profit Margin-2.24%
Operating Margin-8.90%
Return on Equity-1.79%
Return on Assets-1.40%
Shares Outstanding9.06M
Shares Float7.68M
Beta-0.48
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 19, 20201223:1124